PT922034E - Derivados tetra-hidroquinolina como antagonistas de eaa - Google Patents
Derivados tetra-hidroquinolina como antagonistas de eaaInfo
- Publication number
- PT922034E PT922034E PT97943809T PT97943809T PT922034E PT 922034 E PT922034 E PT 922034E PT 97943809 T PT97943809 T PT 97943809T PT 97943809 T PT97943809 T PT 97943809T PT 922034 E PT922034 E PT 922034E
- Authority
- PT
- Portugal
- Prior art keywords
- tetra
- eaa antagonists
- hydroquinoline
- derivatives
- hydroquinoline derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9617305.9A GB9617305D0 (en) | 1996-08-17 | 1996-08-17 | Heterocyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT922034E true PT922034E (pt) | 2002-12-31 |
Family
ID=10798623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97943809T PT922034E (pt) | 1996-08-17 | 1997-08-14 | Derivados tetra-hidroquinolina como antagonistas de eaa |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6479488B1 (pt) |
| EP (1) | EP0922034B1 (pt) |
| JP (1) | JP4108129B2 (pt) |
| KR (1) | KR100552864B1 (pt) |
| CN (1) | CN1131214C (pt) |
| AP (1) | AP877A (pt) |
| AR (1) | AR008296A1 (pt) |
| AT (1) | ATE221052T1 (pt) |
| AU (1) | AU724473B2 (pt) |
| BR (1) | BR9711311B1 (pt) |
| CA (1) | CA2264118C (pt) |
| CO (1) | CO4900066A1 (pt) |
| CZ (1) | CZ296250B6 (pt) |
| DE (1) | DE69714265T2 (pt) |
| DK (1) | DK0922034T3 (pt) |
| EA (1) | EA001704B1 (pt) |
| ES (1) | ES2181030T3 (pt) |
| GB (1) | GB9617305D0 (pt) |
| HU (1) | HU225797B1 (pt) |
| ID (1) | ID18095A (pt) |
| IL (1) | IL128141A0 (pt) |
| IS (1) | IS4953A (pt) |
| MY (1) | MY116952A (pt) |
| NO (1) | NO312241B1 (pt) |
| NZ (1) | NZ333812A (pt) |
| PE (1) | PE107098A1 (pt) |
| PL (1) | PL194532B1 (pt) |
| PT (1) | PT922034E (pt) |
| SI (1) | SI0922034T1 (pt) |
| TR (1) | TR199900336T2 (pt) |
| TW (1) | TW449582B (pt) |
| WO (1) | WO1998007704A1 (pt) |
| YU (1) | YU6799A (pt) |
| ZA (1) | ZA977326B (pt) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9706294D0 (en) * | 1997-03-26 | 1997-05-14 | Glaxo Wellcome Spa | Heterocyclic compound |
| MY125037A (en) | 1998-06-10 | 2006-07-31 | Glaxo Wellcome Spa | 1,2,3,4 tetrahydroquinoline derivatives |
| US6455734B1 (en) | 2000-08-09 | 2002-09-24 | Magnesium Diagnostics, Inc. | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| GB9929037D0 (en) * | 1999-12-08 | 2000-02-02 | Glaxo Wellcome Spa | Heterocyclic derivatives |
| DE10132725A1 (de) | 2001-07-05 | 2006-08-03 | Grünenthal GmbH | Substituierte γ-Lactonverbindungen |
| CN100402032C (zh) * | 2001-12-28 | 2008-07-16 | 阿卡蒂亚药品公司 | 用作毒蕈碱激动剂的四氢喹啉类似物 |
| BRPI0406592A (pt) * | 2003-01-23 | 2005-12-20 | Acadia Pharm Inc | Usos de n-desmetilclozapina, métodos para o tratamento de psicose, de distúrbios afetivos, de demência, de dor neuropática e de glaucoma e composição farmacêutica |
| US20050250767A1 (en) * | 2003-01-23 | 2005-11-10 | Weiner David M | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
| US20050085463A1 (en) * | 2003-01-23 | 2005-04-21 | Weiner David M. | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
| US20060233843A1 (en) * | 2003-02-19 | 2006-10-19 | Conn P J | Treatment of psychosis with a muscarinic m1 receptor ectopic activator |
| US7550454B2 (en) * | 2003-12-22 | 2009-06-23 | Acadia Pharmaceuticals, Inc. | Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| JP2007536216A (ja) * | 2004-04-01 | 2007-12-13 | アカディア ファーマシューティカルズ，インコーポレーテッド | 固体ｎ−デスメチルクロザピンおよびその結晶形を合成および単離する方法 |
| RU2451014C2 (ru) * | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Новое производное гетероциклиден ацетамида |
| BRPI0613771B1 (pt) * | 2005-07-22 | 2021-11-23 | Mochida Pharmaceutical Co., Ltd | Composto derivado de heterociclideno acetamida, composição farmacêutica e antagonista de receptor de tipo i vaniloide com potencial de receptor transitório (trpv1) |
| US8480797B2 (en) | 2005-09-12 | 2013-07-09 | Abela Pharmaceuticals, Inc. | Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors |
| EP2324838A1 (en) * | 2005-09-12 | 2011-05-25 | Abela Pharmaceuticals, Inc. | Compositions Comprising Dimethyl Sulfoxide (DMSO) |
| US7955418B2 (en) | 2005-09-12 | 2011-06-07 | Abela Pharmaceuticals, Inc. | Systems for removing dimethyl sulfoxide (DMSO) or related compounds or odors associated with same |
| WO2007033180A1 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds |
| US20070105836A1 (en) * | 2005-10-31 | 2007-05-10 | Lars Pettersson | Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| BRPI0921494A2 (pt) | 2008-11-03 | 2018-10-30 | Prad Reasearch And Development Ltd | método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração. |
| US9855212B2 (en) | 2009-10-30 | 2018-01-02 | Abela Pharmaceuticals, Inc. | Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases |
| CA2850707C (en) | 2011-10-03 | 2023-03-21 | The University Of Utah Research Foundation | Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL93610A0 (en) | 1989-03-08 | 1990-12-23 | Merck Sharp & Dohme | Tetrahydroquinoline derivatives,their preparation and pharmaceutical compositions containing them |
| WO1997012870A1 (en) * | 1995-09-29 | 1997-04-10 | Glaxo Wellcome S.P.A. | Tetrahydroquinolines as nmda antagonists |
-
1996
- 1996-08-17 GB GBGB9617305.9A patent/GB9617305D0/en active Pending
-
1997
- 1997-08-14 IL IL12814197A patent/IL128141A0/xx not_active IP Right Cessation
- 1997-08-14 ZA ZA977326A patent/ZA977326B/xx unknown
- 1997-08-14 KR KR1019997001280A patent/KR100552864B1/ko not_active IP Right Cessation
- 1997-08-14 YU YU6799A patent/YU6799A/sh unknown
- 1997-08-14 AP APAP/P/1999/001459A patent/AP877A/en active
- 1997-08-14 WO PCT/EP1997/004440 patent/WO1998007704A1/en active IP Right Grant
- 1997-08-14 DE DE69714265T patent/DE69714265T2/de not_active Expired - Lifetime
- 1997-08-14 BR BRPI9711311-5A patent/BR9711311B1/pt not_active IP Right Cessation
- 1997-08-14 CZ CZ0052999A patent/CZ296250B6/cs not_active IP Right Cessation
- 1997-08-14 CN CN97197233A patent/CN1131214C/zh not_active Expired - Fee Related
- 1997-08-14 NZ NZ333812A patent/NZ333812A/xx active Application Revival
- 1997-08-14 AT AT97943809T patent/ATE221052T1/de not_active IP Right Cessation
- 1997-08-14 AU AU45518/97A patent/AU724473B2/en not_active Ceased
- 1997-08-14 SI SI9730404T patent/SI0922034T1/xx unknown
- 1997-08-14 PT PT97943809T patent/PT922034E/pt unknown
- 1997-08-14 PE PE1997000718A patent/PE107098A1/es not_active Application Discontinuation
- 1997-08-14 US US09/147,568 patent/US6479488B1/en not_active Expired - Fee Related
- 1997-08-14 EA EA199900121A patent/EA001704B1/ru not_active IP Right Cessation
- 1997-08-14 CA CA002264118A patent/CA2264118C/en not_active Expired - Fee Related
- 1997-08-14 ID IDP972834A patent/ID18095A/id unknown
- 1997-08-14 JP JP51037298A patent/JP4108129B2/ja not_active Expired - Fee Related
- 1997-08-14 MY MYPI97003742A patent/MY116952A/en unknown
- 1997-08-14 ES ES97943809T patent/ES2181030T3/es not_active Expired - Lifetime
- 1997-08-14 TR TR1999/00336T patent/TR199900336T2/xx unknown
- 1997-08-14 DK DK97943809T patent/DK0922034T3/da active
- 1997-08-14 AR ARP970103703A patent/AR008296A1/es active IP Right Grant
- 1997-08-14 CO CO97046782A patent/CO4900066A1/es unknown
- 1997-08-14 EP EP97943809A patent/EP0922034B1/en not_active Expired - Lifetime
- 1997-08-14 HU HU9903108A patent/HU225797B1/hu not_active IP Right Cessation
- 1997-08-14 PL PL97331562A patent/PL194532B1/pl not_active IP Right Cessation
- 1997-08-30 TW TW086112442A patent/TW449582B/zh not_active IP Right Cessation
-
1999
- 1999-01-22 IS IS4953A patent/IS4953A/is unknown
- 1999-02-16 NO NO19990723A patent/NO312241B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT922034E (pt) | Derivados tetra-hidroquinolina como antagonistas de eaa | |
| PT946512E (pt) | Derivados de 6-fenilpiridil-2-amina uteis como inibidores de nos | |
| BR9700850A (pt) | Derivados de quinazolina substituídos | |
| PT1084114E (pt) | Derivados isotiazole uteis como agentes anticancerigenos | |
| PT1028961E (pt) | Derivados de pleuromutilina como agentes antimicrobianos | |
| BR9707391A (pt) | Pirazolpirimidinas como antagonistas de receptor de crf | |
| PT934320E (pt) | Derivados de naftiridina | |
| DE69706292T2 (de) | Chinazoline derivate | |
| ATE216999T1 (de) | Pyrimidin-4-on derivate als pestizidesmittel | |
| PT994890E (pt) | Derivados de benzimidazole | |
| ATE215950T1 (de) | Carbolinderivate | |
| PT1073639E (pt) | Derivados de quinolina | |
| PT1005446E (pt) | Derivados de n-aroilfenilalanina | |
| PT1095021E (pt) | Derivados de quinolina | |
| PT915088E (pt) | Derivados de d-prolina | |
| DE69731747D1 (de) | Peptid derivate | |
| PT1003719E (pt) | Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida | |
| BR9709065A (pt) | Derivados de alquilaminobenzotiazole e-benzoxazol | |
| BR9702328A (pt) | Derivados de 4-aralquilaminopirimidina bicíclicos como inibidores de quinase tirosina | |
| PT1027362E (pt) | Derivados de cetolidos 2-halogeno-6-o-substituidos | |
| PT1027342E (pt) | Derivados de ciclopentenos uteis como antagonistas do receptor da motilina | |
| PT1023268E (pt) | Isoquinolinas como inibidores de uroquinase | |
| PT854867E (pt) | Tetra-hidroquinolinas como antagonistas de nmda | |
| PT1140931E (pt) | Antagonistas de 5hti para terapia antidepressiva | |
| PT1056716E (pt) | Derivados de ciclo-hexanodiolo |